- Home
- AUST vs PYPD Comparison
AUST vs PYPD Comparison
Compare AUST & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUST
- PYPD
- Stock Information
- Founded
- AUST 2020
- PYPD 2008
- Country
- AUST Canada
- PYPD Israel
- Employees
- AUST N/A
- PYPD N/A
- Industry
- AUST
- PYPD Medical/Dental Instruments
- Sector
- AUST
- PYPD Health Care
- Exchange
- AUST Nasdaq
- PYPD Nasdaq
- Market Cap
- AUST 18.0M
- PYPD 26.7M
- IPO Year
- AUST 2022
- PYPD 2020
- Fundamental
- Price
- AUST $1.34
- PYPD $2.77
- Analyst Decision
- AUST
- PYPD Strong Buy
- Analyst Count
- AUST 0
- PYPD 2
- Target Price
- AUST N/A
- PYPD $10.50
- AVG Volume (30 Days)
- AUST 90.3K
- PYPD 15.1K
- Earning Date
- AUST 05-20-2025
- PYPD 05-14-2025
- Dividend Yield
- AUST N/A
- PYPD N/A
- EPS Growth
- AUST N/A
- PYPD N/A
- EPS
- AUST N/A
- PYPD N/A
- Revenue
- AUST N/A
- PYPD N/A
- Revenue This Year
- AUST N/A
- PYPD N/A
- Revenue Next Year
- AUST N/A
- PYPD N/A
- P/E Ratio
- AUST N/A
- PYPD N/A
- Revenue Growth
- AUST N/A
- PYPD N/A
- 52 Week Low
- AUST $0.79
- PYPD $2.30
- 52 Week High
- AUST $3.19
- PYPD $4.75
- Technical
- Relative Strength Index (RSI)
- AUST 53.82
- PYPD 52.30
- Support Level
- AUST $1.19
- PYPD $2.71
- Resistance Level
- AUST $1.26
- PYPD $2.89
- Average True Range (ATR)
- AUST 0.09
- PYPD 0.15
- MACD
- AUST 0.01
- PYPD 0.02
- Stochastic Oscillator
- AUST 77.78
- PYPD 40.00
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.